Celerion Revenue
Pharmaceutical Manufacturing • 
Lincoln, Nebraska, United States • 1001-2000 Employees
Celerion revenue & valuation
| Annual revenue | $24,300,000 |
| Revenue per employee | $22,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $77,800,000 |
| Total funding | No funding |
Key Contacts at Celerion
Gregory Austin
Director, Business Development Bioanalysis
Andrew Baxter
Senior Director Business Development - Global Early Clinical Development Solutions
Aron Robinson
Business Development Director, Bioanalytical Services
Nathan Mccavery
Senior Director, Business Development Europe
Rebecca Wright
Senior Director Business Development
Kim Lapeirre
Director, Business Development
Aricia Pfaff
Executive Director Business Development
Sam Fricke
Director, Business Development
Allan Cortes
Director, Business Development Bioanalysis
Emanuel Owens
Director, Business Development
Company overview
| Headquarters | 621 Rose Street, Lincoln, NE 68502, US |
| Phone number | +14024762811 |
| Website | |
| NAICS | 3254 |
| SIC | 873 |
| Keywords | Global Clinical Development, Drug Development Services, Applied Translational Medicine, Data Management And Biometrics, Global Clinical Research (Phase I And Ii, Nda-Enabling Clinical Pharmacology) |
| Founded | 2010 |
| Employees | 1001-2000 |
| Socials |
Celerion Email Formats
Celerion uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@celerion.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@celerion.com | 50% |
{first name}.{last name} | john.doe@celerion.com | 48.7% |
About Celerion
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines. With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings. Our operations are strategically located in: Lincoln, Nebraska (Corporate Headquarters) Philadelphia, Pennsylvania Phoenix, Arizona Belfast, Northern Ireland,UK Zurich, Switzerland Vienna, Austria Richmond, Virginia Montreal, Quebec, Canada For more information, visit: www.celerion.com
Employees by Management Level
Total employees: 1001-2000
Seniority
Employees
Employees by Department
Celerion has 514 employees across 12 departments.
Departments
Number of employees
Funding Data
Celerion has never raised funding before.
Celerion Tech Stack
Discover the technologies and tools that power Celerion's digital infrastructure, from frameworks to analytics platforms.
Recruitment & staffing
Issue trackers
WordPress plugins
JavaScript libraries
CDN
Marketing automation
Databases
JavaScript libraries
Advertising
Programming languages
Security
Argentina
Netherlands
Australia
Frequently asked questions
4.8
40,000 users
